1 – 83 of 83
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Tumor-associated fibrosis : a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination
2024) In Cancer and Metastasis Reviews(
- Contribution to journal › Scientific review
-
Mark
Cancer Evolution under Chemotherapy Treatment
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
An explainable machine learning model to solid adnexal masses diagnosis based on clinical data and qualitative ultrasound indicators
(
- Contribution to journal › Article
- 2023
-
Mark
A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
(
- Contribution to journal › Article
-
Mark
The prognostic impact of limited-staging surgery in patients with stage IA epithelial ovarian cancer : a multi-center study with a propensity score-adjusted analysis
(
- Contribution to journal › Article
-
Mark
805P Tumor-informed ctDNA detection as a predictive marker for postoperative residual disease in epithelial ovarian cancer: A feasibility study
(
- Contribution to journal › Published meeting abstract
-
Mark
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Small Extracellular Vesicles from adipose-derived stem cells suppress cell proliferation by delivering the let-7 family of microRNAs in ovarian cancer
(
- Contribution to journal › Article
-
Mark
#898 Tumor-informed ctDNA detection as a marker for postoperative residual disease in epithelial ovarian cancer : results of a feasibility study
(
- Contribution to journal › Published meeting abstract
- 2022
-
Mark
Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis
(
- Contribution to journal › Article
-
Mark
Risk of Gynecological Cancers in Cholecystectomized Women : A Large Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
(
- Contribution to journal › Article
-
Mark
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation : OPINION primary analysis
(
- Contribution to journal › Article
-
Mark
Circulating Markers of Neutrophil Extracellular Traps (NETs) in Patients With Ovarian Tumors
(
- Contribution to journal › Article
-
Mark
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report
(
- Contribution to journal › Article
-
Mark
Preoperative circulating tumor DNA level is associated to poor overall survival in patients with ovarian cancer
(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Ultrasound, macroscopic and histological features of malignant ovarian tumors
(
- Contribution to journal › Article
-
Mark
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
-
Mark
Ovarian cancer-associated mesothelial cells : Transdifferentiation to minions of cancer and orchestrate developing peritoneal dissemination
(
- Contribution to journal › Scientific review
-
Mark
Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting
(
- Contribution to journal › Article
-
Mark
Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer
(
- Contribution to journal › Article
-
Mark
Polyphenol intake and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (Epic) study
(
- Contribution to journal › Article
-
Mark
Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer : a multi-institutional study with an in-depth subgroup analysis
(
- Contribution to journal › Article
-
Mark
Precision oncology of high-grade ovarian cancer defined through targeted sequencing
(
- Contribution to journal › Article
-
Mark
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
(
- Contribution to journal › Article
-
Mark
Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer
(
- Contribution to journal › Article
-
Mark
Areas to improve quality of life after ovarian tumor surgery and adjuvant treatment
(
- Contribution to journal › Article
-
Mark
Comprehending the proteomic landscape of ovarian cancer : A road to the discovery of disease biomarkers
(
- Contribution to journal › Scientific review
-
Mark
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014 : A population-based cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
The NF-κB modulated miR-194-5p/IGF1R/PPFIBP axis is crucial for the tumorigenesis of ovarian cancer
(
- Contribution to journal › Article
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
(
- Contribution to journal › Article
-
Mark
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk : Results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Microphthalmia-associated transcription factor-dependent melanoma cell adhesion molecule activation promotes peritoneal metastasis of ovarian cancer
(
- Contribution to journal › Article
-
Mark
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
(
- Contribution to journal › Article
- 2019
-
Mark
Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2
(
- Contribution to journal › Article
-
Mark
Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The NF-κB-modulated miR-19a-3p enhances malignancy of human ovarian cancer cells through inhibition of IGFBP-3 expression
(
- Contribution to journal › Article
-
Mark
Development and validation of circulating CA125 prediction models in postmenopausal women
(
- Contribution to journal › Article
- 2018
-
Mark
Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels : Results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication
(
- Contribution to journal › Article
-
Mark
Prophylactic 3-hour graduated infusion schedule minimizes risk of carboplatin hypersensitivity reactions - A prospective study
(
- Contribution to journal › Article
-
Mark
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
(
- Contribution to journal › Article
-
Mark
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy
(
- Contribution to journal › Article
-
Mark
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) as Primary Treatment of Ovarian Cancer : A Review of the Current Literature
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation
(
- Contribution to journal › Article
-
Mark
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
(
- Contribution to journal › Article
-
Mark
Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models : results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Multi-parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour-type-specific stroma phenotypes and a novel vascular biomarker
(
- Contribution to journal › Article
- 2016
-
Mark
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Intrinsic subtypes and prognostic implications in epithelial ovarian cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
(
- Contribution to journal › Article
-
Mark
Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort
(
- Contribution to journal › Article
- 2014
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type: The PaLiDo Study, a Phase II Nonrandomized Multicenter Study.
(
- Contribution to journal › Article
- 2012
-
Mark
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
(
- Contribution to journal › Article
-
Mark
Discovery of Dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study
(
- Contribution to journal › Article
-
Mark
Bevacizumab in the treatment of ovarian cancer
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Towards improved management of Lynch syndrome; ovarian cancer profiles, risk perception, knowledge and family perspectives
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer?
(
- Contribution to journal › Article
-
Mark
Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994
(
- Contribution to journal › Article
-
Mark
Central nervous system metastases from epithelial ovarian cancer : Prognostic factors and outcome
(
- Contribution to journal › Article
- 2010
-
Mark
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
SOX11 as a Cancer Biomarker - Expression and Regulatory Studies in B-cell Lymphomas and Ovarian Cancer
2010)(
- Thesis › Doctoral thesis (compilation)
- 2009
-
Mark
High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma
(
- Contribution to journal › Article
-
Mark
Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas
(
- Contribution to journal › Article
- 2008
-
Mark
The uPA receptor in ovarian cancer. Regulation by EGF and the estrogen responsive membrane receptor GPR30. Soluble uPAR in diagnosis and prognosis.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Real-time ultrasound vs. evaluation of static images in the preoperative assessment of adnexal masses
(
- Contribution to journal › Article
- 2006
-
Mark
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
(
- Contribution to journal › Article
- 2005
-
Mark
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: Implications for breast and ovarian cancer risk.
(
- Contribution to journal › Article
- 2002
-
Mark
A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein
(
- Contribution to journal › Article
-
Mark
Balancing - Cancer from a primary care perspective. Diagnosis, posttraumatic stress, and end-of-life care.
2002)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series
(
- Contribution to journal › Article
-
Mark
Genetic epidemiology of BRCA1 mutations in Norway
(
- Contribution to journal › Article
-
Mark
Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation
(
- Contribution to journal › Article
-
Mark
Molecular Genetic Alterations In Endometrial And Ovarian Cancers
2001)(
- Thesis › Doctoral thesis (compilation)
- 1999
-
Mark
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
(
- Contribution to journal › Article
-
Mark
Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses
(
- Contribution to journal › Article